Articles with the topic: featured

The genetic 'gray area' of Huntington's disease: what does it all mean?

Intermediate alleles and reduced penetrance – the genetic 'gray area' of Huntington’s disease, explained

Dr Nayana Lahiri | April 22, 2011

Dimebon fails in late-stage human HD clinical trial

Dimebon fails to improve symptoms in HD patients in the HORIZON trial

Dr Jeff Carroll | April 11, 2011

Gene silencing for HD: the story so far

Is gene silencing as exciting as it sounds for HD, and what might the future hold?

Professor Ed Wild | March 22, 2011

Interview: Graeme Bilbe, Global Head for Neuroscience at Novartis

HDBuzz interviews Graeme Bilbe, Global Head for Neuroscience at pharmaceutical giant Novartis, about their HD researc

Professor Ed Wild | March 14, 2011

Interview: CHDI Management

HDBuzz interviews three top scientists from CHDI, the biggest funder and driver of HD research worldwide

Dr Jeff Carroll | February 25, 2011

CHDI Report: Day 3

Day 3 of CHDI’s HD therapeutics conference: growth factors and CHDI’s advanced therapies

Dr Jeff Carroll | February 10, 2011

CHDI Report: Day 2

Day 2 of CHDI’s HD therapeutics conference: figuring out energy problems in HD

Professor Ed Wild | February 09, 2011

CHDI Report: Day 1

Day 1 of CHDI’s HD therapeutics conference: exploring abnormal brain connections and silencing the HD gene

Dr Jeff Carroll | February 08, 2011

Welcome to HDBuzz

Welcome to HDBuzz. Huntington’s disease research news. In plain language. Written by scientists. For the global HD co